Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
- PMID: 32301750
- DOI: 10.1515/cclm-2020-0473
Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
Keywords: COVID-19; coronavirus; immunoassay.
References
-
- Lippi G, Sanchis-Gomar F, Henry BM. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med 2020;58:1063–9.
-
- Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med 2020. doi: 10.1515/cclm-2020-0240. [Epub ahead of print].
-
- Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19) – Information for Laboratories. Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html. Last accessed April 7, 2020.
-
- Petherick A. Developing antibody tests for SARS-CoV-2. Lancet 2020;395:1101–2.
-
- Padoan A, Cosma C, Sciacovelli L, Faggian D, Plebani M. Analytical performances of a chemiluminescence immunoassay for 2019-nCov IgM/IgG and antibody kinetics. Clin Chem Lab Med 2020;58:1081–8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous